Lably
Skip to content

Extracorporeal shockwave therapy

Ultrasonic, non-invasive, outpatient treatment

  • 3 min read
  • 4 chapters

Related on Lably

Through Liver

History

Beginning in 1969, funded by the German Ministry of Defense, Dornier began a study of the effects of shock waves on tissue. In 1972, on the basis of Dornies' preliminary studies, an agreement was reached with Egbert Schmiedt, director of the urologic clinic at LMU Munich. The development of the Dornier lithotripter progressed through prototypes, culminating in February 1980 with the first treatment of a human. The production and distribution of the Dornier HM3 lithotripter began in late 1983, and ESWT was approved by the U.S. Food and Drug Administration in 1984.

In the 1980s people using ESWT for kidney stones noticed that it appeared to increase bone density in nearby bones, leading them to explore it for orthopedic purposes.

Sign in to keep reading

3 more chapters are free with a Lably account.

More in Health